Omeros (OMER) EBT Margin (2010 - 2026)
Omeros' (OMER) quarterly EBT Margin came in at 518.61% in Q1 2026, up 785.39% quarter-over-quarter from 75.67% in Q3 2021.
Omeros (OMER) EBT Margin (2010 - 2026) Analysis & Trends
Omeros has disclosed EBT Margin across 13 years of filings, most recently posting 518.61% for Q1 2026.
- EBT Margin for Q1 2026 came in at 518.61%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 42.1% (up 17577.0% YoY), and the FY2020 annual result was 266.06%, down 11657.0% from the prior year.
- EBT Margin came in at 518.61% for Q1 2026 at Omeros, up from 75.67% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 518.61% in Q1 2026 to a low of 518.61% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 518.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 518.61% |
| Sep 30, 2021 | -75.67% |
| Jun 30, 2021 | -175.28% |
| Mar 31, 2021 | -238.29% |
| Dec 31, 2020 | -825.31% |
| Sep 30, 2020 | -177.36% |
| Jun 30, 2020 | -248.77% |
| Mar 31, 2020 | -125.67% |
| Dec 31, 2019 | -334.80% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -55.58% |
| Mar 31, 2019 | -114.05% |
| Dec 31, 2018 | -107.29% |
| Sep 30, 2018 | -869.01% |
| Jun 30, 2018 | -2,072.08% |
| Mar 31, 2018 | -1,921.54% |
| Dec 31, 2017 | -123.44% |
| Sep 30, 2017 | -36.43% |
| Jun 30, 2017 | -85.49% |
| Mar 31, 2017 | -125.54% |